Innovotech

Innovotech Equity Growth

The Year-over-Year Equity Growth of Innovotech (IOT.V) as of Nov 20, 2026 is 40.23 %. In the previous year, Year-over-Year Equity Growth was 175.64 % — a change of -77.10% (lower).

Equity Growth

40.23 %

YoY

-77.10%

Last updated:

Year-over-Year Equity Growth of Innovotech is 2025 40.23 % . Year-over-Year Equity Growth of Innovotech was 2024 175.64 % . It decreases by -77.10% lower compared to the previous year.

The Innovotech Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
-48.50 CAD
Jan 1, 2019
4.94 CAD
Jan 1, 2020
557.56 CAD
Jan 1, 2021
82.48 CAD
Jan 1, 2022
-10.15 CAD
Jan 1, 2023
-12.00 CAD
Jan 1, 2024
175.64 CAD
Jan 1, 2025
40.23 CAD
The Innovotech Equity Growth history
YEAREquity GrowthYoY
40.23 %-77.10%
175.64 %-1,563.58%
-12.00 %+18.27%
-10.15 %-112.30%
82.48 %-85.21%
557.56 %+11,187.60%
4.94 %-110.18%
-48.50 %-142.22%
114.90 %-634.64%
-21.49 %-30.65%
-30.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innovotech Stock analysis

What does Innovotech do? Innovotech Inc. generates revenue through the sale of proprietary assay kits, including MBEC Assay Kits, Order Biofilm Assays, and Coated MBEC Assay Lids, which are used in microbial biofilm research. The company also provides contract research services such as Antimicrobial Contract Research, Antimicrobial and Anti-Biofilm Agents testing (MIC and MBEC), and Customized Antimicrobial Testing (BEST Assay Testing and Implanted Medical Device Testing). Its antimicrobial silver products, AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products, are sold to customers in agricultural and medical sectors. The firm targets research institutions, agricultural producers, and medical device manufacturers seeking biofilm and antimicrobial testing solutions. Innovotech's intellectual property portfolio supports its contract research services, which include testing for antimicrobial agents and materials under standards like TM100, ISO 22196, and USP 51. The company’s Biofilm Publications and SEM Library serve as additional resources for clients engaged in biofilm research. Its product offerings are tailored to sectors requiring microbial biofilm analysis, such as crop protection and medical device development, with AgreGuard-1 and InnovoSIL products specifically addressing antimicrobial needs in agriculture and medical applications. The company monetizes its proprietary technology through direct sales of assay kits and antimicrobial silver products, while contract research services provide recurring revenue streams. Clients include research organizations conducting biofilm studies, agricultural businesses using AgreGuard-1 for crop protection, and medical device manufacturers utilizing InnovoSIL for antimicrobial properties. Innovotech’s focus on specialized testing methodologies and branded products ensures consistent demand from niche markets requiring precise biofilm and antimicrobial evaluation. Innovotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innovotech stock

Year-over-Year Equity Growth of Innovotech is 40.23 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Innovotech since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Innovotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Innovotech

All Key Metrics — Innovotech